Gemin X's Series E Round

Gemin X raised a round of funding on August 10, 2010.

Gemin X Pharmaceuticals is dedicated to the discovery, development and commercialization of novel, targeted cancer therapeutics to improve the lives of patients.…

Articles about Gemin X's Series E Round: